CHARISSA MONTGOMERY: Open Payments
NPI 1326558503 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,007 in 21 payments from 10 companies in 2025. Trend: 2023 $218 · 2024 $400 · 2025 $1,007
Speaker / faculty: $426Food & beverage: $385Travel & lodging: $196
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $642 |
| Daiichi Sankyo Inc. | 5 | $119 |
| Janssen Biotech, Inc. | 4 | $99 |
| Pharmacosmos Therapeutics Inc. | 2 | $39 |
| Tempus AI, Inc | 1 | $21 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| Caris MPI, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| SOBI, INC | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: Vanflyta, ERLEADA, ENHERTU, MONOFERRIC, XT CDX, ULTOMIRIS, MI CANCER SEEK, KEYTRUDA.
Industry payments across PA — which companies pay providers there.
